prucalopride
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract The most relevant risk factors for the development of chronic constipation are neurologic disorders such as Parkinson’s…
Constipation is a frequent complaint, especially in women and the elderly. It is sometimes drug-induced, and is only occasionally…
Im Herbst 2009 hat die europäische Arzneimittelbehörde EMEA die prokinetische Substanz Prucaloprid zugelassen zur Behandlung der…
Introduction Chronic Idiopathic Constipation (CIC) is a functional disorder of the gastrointestinal tract. Patients often self…
Prucalopride (Resolor) is a new treatment for women with chronic constipation who have not responded to conventional laxatives…
Deficiencies in both the completeness and transparency of key aspects of the evaluation and appraisal process mean that that the…
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept…
SUMMARY
The last decade has been marked by substantial progress
in the understanding of the pathophysiology of Irritable
Bowel…
Purpose: Constipation is a common disorder in the elderly and there is a need for more effective and better-tolerated drugs that…